N
Nicola E. Hiemann
Publications - 55
Citations - 1875
Nicola E. Hiemann is an academic researcher. The author has contributed to research in topics: Heart transplantation & Transplantation. The author has an hindex of 16, co-authored 55 publications receiving 1687 citations.
Papers
More filters
Journal ArticleDOI
International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy—2010
Mandeep R. Mehra,María G. Crespo-Leiro,Anne I. Dipchand,Stephan M. Ensminger,Nicola E. Hiemann,Jon A. Kobashigawa,Joren C. Madsen,Jayan Parameshwar,Randall C. Starling,Patricia A. Uber +9 more
TL;DR: This consensus document is based on best evidence and clinical consensus derived from critical analysis of available information pertaining to angiography, intravascular ultrasound imaging, microvascular function, cardiac allograft histology, circulating immune markers, non-invasive imaging tests, and gene-based and protein-based biomarkers.
Journal ArticleDOI
Report from a consensus conference on antibody-mediated rejection in heart transplantation
Jon A. Kobashigawa,María G. Crespo-Leiro,Stephan M. Ensminger,Hermann Reichenspurner,Annalisa Angelini,Gerald J. Berry,Margaret Burke,Lawrence S.C. Czer,Nicola E. Hiemann,Abdallah G. Kfoury,Donna Mancini,Paul Mohacsi,Jignesh Patel,Naveen L. Pereira,Jeffrey L. Platt,Elaine F. Reed,Nancy L. Reinsmoen,E. Rene Rodriguez,Marlene L. Rose,Stuart D. Russell,Randy Starling,Nicole Suciu-Foca,Jose A. Tallaj,David O. Taylor,Adrian B. Van Bakel,Lori J. West,Adriana Zeevi,Andreas Zuckermann +27 more
TL;DR: A clinical definition for AMR (cardiac dysfunction and/or circulating donor-specific antibody) was no longer believed to be required due to recent publications demonstrating that asymptomatic (no cardiac dysfunction) biopsy-proven AMR is associated with subsequent greater mortality and greater development of cardiac allograft vasculopathy.
Journal ArticleDOI
Prognostic Impact of Microvasculopathy on Survival After Heart Transplantation Evidence From 9713 Endomyocardial Biopsies
Nicola E. Hiemann,Ernst Wellnhofer,Christoph Knosalla,Hans B. Lehmkuhl,Julia Stein,Roland Hetzer,Rudolf Meyer +6 more
TL;DR: Stenotic microvasculopathy is frequent in routinely processed biopsies and a new prognostic factor for long-term survival after heart transplantation, independent of epicardial transplant vasculopathy.
Journal ArticleDOI
Non-HLA antibodies targeting vascular receptors enhance alloimmune response and microvasculopathy after heart transplantation.
Nicola E. Hiemann,Rudolf Meyer,Ernst Wellnhofer,Constanze Schoenemann,Harald Heidecke,Nils Lachmann,Roland Hetzer,Duska Dragun +7 more
TL;DR: Elevated levels of AT1R and ETAR Abs are associated with cellular and Ab-mediated rejection and early onset of microvasculopathy and should be routinely monitored after heart transplantation.
Journal ArticleDOI
Prognostic Impact of Microvasculopathy on Survival after Heart Transplantation
TL;DR: Stenotic microvasculopathy is frequent in routinely processed biopsies and a new prognostic factor for long-term survival after heart transplantation, independent of epicardial transplant vasculopathy.